These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37315423)

  • 1. Generation of a human induced pluripotent stem cell line (UQi001-A-1) edited with the CRISPR-Cas9 system to carry the heterozygous TARDBP c.1144G > A (p.A382T) missense mutation.
    Tracey TJ; Jiang L; Gill MK; Ranie SN; Ovchinnikov DA; Wolvetang EJ; Ngo ST
    Stem Cell Res; 2023 Aug; 70():103137. PubMed ID: 37315423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis.
    Corrado L; Ratti A; Gellera C; Buratti E; Castellotti B; Carlomagno Y; Ticozzi N; Mazzini L; Testa L; Taroni F; Baralle FE; Silani V; D'Alfonso S
    Hum Mutat; 2009 Apr; 30(4):688-94. PubMed ID: 19224587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line (UCSCi002-A) from a patient with a variant in TARDBP gene associated with familial amyotrophic lateral sclerosis and frontotemporal dementia.
    Martello F; Lattante S; Doronzio PN; Conte A; Bisogni G; Orteschi D; Luigetti M; Marrucci MA; Zollino M; Sabatelli M; Marangi G
    Stem Cell Res; 2022 Jul; 62():102825. PubMed ID: 35667216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
    Rutherford NJ; Zhang YJ; Baker M; Gass JM; Finch NA; Xu YF; Stewart H; Kelley BJ; Kuntz K; Crook RJ; Sreedharan J; Vance C; Sorenson E; Lippa C; Bigio EH; Geschwind DH; Knopman DS; Mitsumoto H; Petersen RC; Cashman NR; Hutton M; Shaw CE; Boylan KB; Boeve B; Graff-Radford NR; Wszolek ZK; Caselli RJ; Dickson DW; Mackenzie IR; Petrucelli L; Rademakers R
    PLoS Genet; 2008 Sep; 4(9):e1000193. PubMed ID: 18802454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein.
    D'Anzi A; Altieri F; Perciballi E; Ferrari D; Torres B; Bernardini L; Lattante S; Sabatelli M; Vescovi AL; Rosati J
    Stem Cell Res; 2021 May; 53():102356. PubMed ID: 34087986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
    Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
    Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
    Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
    Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation P525L (c.1574C > T) in FUS gene.
    Akter M; Cui H; Abir Hosain M; Ding B
    Stem Cell Res; 2023 Jun; 69():103103. PubMed ID: 37116345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein.
    D'Anzi A; Perciballi E; Ruotolo G; Ferrari D; Notaro A; Lombardi I; Gelati M; Frezza K; Bernardini L; Torrente I; De Luca A; La Bella V; Luigi Vescovi A; Rosati J
    Stem Cell Res; 2022 Aug; 63():102835. PubMed ID: 35714448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic architecture of ALS in Sardinia.
    Borghero G; Pugliatti M; Marrosu F; Marrosu MG; Murru MR; Floris G; Cannas A; Parish LD; Occhineri P; Cau TB; Loi D; Ticca A; Traccis S; Manera U; Canosa A; Moglia C; Calvo A; Barberis M; Brunetti M; Pliner HA; Renton AE; Nalls MA; Traynor BJ; Restagno G; Chiò A;
    Neurobiol Aging; 2014 Dec; 35(12):2882.e7-2882.e12. PubMed ID: 25123918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced stress granule formation and cell death in fibroblasts with the A382T mutation of TARDBP gene: evidence for loss of TDP-43 nuclear function.
    Orrù S; Coni P; Floris A; Littera R; Carcassi C; Sogos V; Brancia C
    Hum Mol Genet; 2016 Oct; 25(20):4473-4483. PubMed ID: 28172957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing.
    Lilianty J; Bateman JF; Lamandé SR
    Stem Cell Res; 2021 Oct; 56():102515. PubMed ID: 34543885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a heterozygous TPM1-E192K knock-in human induced pluripotent stem cell line using CRISPR/Cas9 system.
    Kang JY; Mun D; Chun Y; Kim H; Yun N; Lee SH; Joung B
    Stem Cell Res; 2022 Aug; 63():102878. PubMed ID: 35917600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations.
    Del Bo R; Ghezzi S; Corti S; Pandolfo M; Ranieri M; Santoro D; Ghione I; Prelle A; Orsetti V; Mancuso M; Sorarù G; Briani C; Angelini C; Siciliano G; Bresolin N; Comi GP
    Eur J Neurol; 2009 Jun; 16(6):727-32. PubMed ID: 19236453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing.
    Lilianty J; Nur Patria Y; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 May; 45():101843. PubMed ID: 32446218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation.
    Hua M; Williams L; Burns K; Liu S; Ellis J; Innes AM; McPherson M; Yang G
    Stem Cell Res; 2024 Apr; 76():103344. PubMed ID: 38364506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel TARDBP insertion/deletion mutation in the flail arm variant of amyotrophic lateral sclerosis.
    Solski JA; Yang S; Nicholson GA; Luquin N; Williams KL; Fernando R; Pamphlett R; Blair IP
    Amyotroph Lateral Scler; 2012 Sep; 13(5):465-70. PubMed ID: 22424122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.